Athersys (NASDAQ:ATHX) Now Covered by StockNews.com

StockNews.com assumed coverage on shares of Athersys (NASDAQ:ATHX) in a research report sent to investors on Friday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock.

Athersys Stock Up 99,900.0 %

Shares of ATHX stock opened at $0.00 on Friday. Athersys has a fifty-two week low of $0.01 and a fifty-two week high of $1.99. The stock has a market cap of $61,719.00, a P/E ratio of 0.00 and a beta of -0.90.

Athersys Company Profile

Athersys, Inc, a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions.